Management of primary or secondary sclerosing cholangitis is challenging. These Clinical
Practice Guidelines have been developed to provide practical guidance on debated topics …

The global burden of chronic liver disease (CLD) is substantial. Due to the limited indication
of and accessibility to antiviral therapy in viral hepatitis and lack of effective pharmacological …

Morbidly obese and post-bariatric surgery patients are at increased risk for biliary stones
formation. The complications related to biliary stones may impose complexity on their …

Background It remains unclear whether ursodeoxycholic acid (UDCA) treatment improves
long-term outcomes in patients with primary sclerosing cholangitis (PSC). In this study, we …

METHODS: An 18-week proof-of-concept study was conducted to assess the safety and
efficacy of HTD1801 in PSC. This study had three 6-week periods:(i) a placebo-controlled …

2015 年我国第一个原发性硬化性胆管炎(Psc) 的专家共识颁布. 近年来Psc
的临床研究提供了Psc 新的研究数据和资料. 为此, 中华医学会肝病学分会自身免疫性肝病学组 …

Patients with long-term inflammatory bowel disease (IBD) have an increased risk of
developing cancer of the colon. In 1925, Crohn and Rosenberg called attention to the …

Objectives: This proof-of-concept, open-label phase 1b study evaluated the safety and
efficacy of cilofexor, a potent selective farnesoid X receptor agonist, in patients with …

Prediction of outcome in autoimmune hepatitis and ariant s ndromes Page 1 Prediction of
outcome in autoimmune hepatitis and ariant s ndromes Biewenga, M. Citation Biewenga, M …